Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis

Published:2016-10-21 Issue:1 Volume:17 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Tan Jingwen,Liu Shuiqing,Segal Jodi B.,Alexander G. Caleb,McAdams-DeMarco Mara

Funder

National Heart, Lung, and Blood Institute

Johns Hopkins Bloomberg School of Public Health

American Society of Nephrology

Johns Hopkins University

National Institute on Aging

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-016-0368-6.pdf

Reference44 articles.

1. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant. 2012;27(10):3816–22.

2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.

3. Providencia R, Marijon E, Boveda S, Barra S, Narayanan K, Le Heuzey JY, Gersh BJ, Goncalves L. Meta-analysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation. Am J Cardiol. 2014;114(4):646–53.

4. Bai Y, Chen H, Yang Y, Li L, Liu XY, Shi XB, Ma CS. Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review. Thromb Res. 2016;137:46–52.

5. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland Jr JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199–267.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation in Chronic Kidney Disease;Drugs;2024-08-09

2. Latest Concepts in the Endodontic Management of Kidney Patients;Cureus;2024-02-19

3. Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study;Clinical Kidney Journal;2024-02-01

4. Anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: Arguments for or against;Medical alphabet;2023-11-08

5. Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation;Mayo Clinic Proceedings;2023-05